ChatGPT shows potential for assisting in bone tumor diagnosis
ChatGPT shows potential in helping radiologists to identify malignant bone tumors based on CT imaging findings in radiology reports, according to a study published January 22 in the Journal of Bone Oncology.
A team led by Fan Yang, MD, of Capital Medical University in Beijing reported that a few-shot trained ChatGPT model (that is, a model trained to make accurate predictions with only a small number of examples) showed 87% accuracy and 99% sensitivity for flagging malignant bone tumors.
"Our findings highlight the potential of ChatGPT in the diagnosis of benign and malignant bone tumors, offering advantages like enhance...
Source: AuntMinnie.com Headlines - January 23, 2024 Category: Radiology Authors: Kate Madden Yee Tags: CT Source Type: news
Consider Cancer as a Trigger for Deep Vein Thrombosis Consider Cancer as a Trigger for Deep Vein Thrombosis
Examination of a woman with paranoid schizophrenia and deep vein thrombosis revealed chondrosarcoma of the tibia.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - May 12, 2022 Category: Internal Medicine Tags: Cardiology News Source Type: news
20.09.19: Not intended for U.S. and UK Media - European Society for Medical Oncology (ESMO) Congress 2019
Bayer data at ESMO 2019 highlights innovation in cancer researchNew data for larotrectinib on durability of response in patients with TRK fusion cancer to be presented in a poster discussion on September 28 / Data from Bayer's prostate cancer franchise to be presented, including clinical relevance of drug-drug interactions in men with nmCRPC taking darolutamide and real-world data and pain evalutation data in men with mCRPC treated with radium-223 dichloride / New analyses from the Phase II study REGOBONE evaluating the efficacy and safety of regorafenib in patients with rare locally advanced or metastatic relapsed chondro...
Source: Bayer IR Newsfeed: Events - September 20, 2019 Category: Pharmaceuticals Source Type: news
Namibia:Cancer Patient to Lose Arm
[New Era] Windhoek -A 21-year-old man diagnosed with chondrosarcoma is struggling to accept his diagnosis. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 10, 2018 Category: African Health Source Type: news
Anatomics ’ custom 3D-printed sternum implant used in US 1st replacement procedure
Anatomics said this month that a custom 3D-printed implant it created was successfully implanted to replace the sternum and partial ribcage of a 20-year old patient who had lost significant bone mass to Chondrosarcoma, touting the procedure as a 1st for the US.
The implant was composed of composite titanium and porous polyethylene designed using high-resolution CT scans of the patient’s chest, approved by an operating surgeon. The implant was only the 2nd of its kind to use the company’s PoreStar technology, though Anatomics has been innovating in the field of 3D printing for over 2 decades.
Anatomics has been ...
Source: Mass Device - October 27, 2017 Category: Medical Devices Authors: Fink Densford Tags: Implants Research & Development Surgical anatomics Source Type: news
What Charlotte Rae's Cancer Plan Reveals About Medical Decisions Late In Life
Actress Charlotte Rae, 91, has revealed that she was just diagnosed with bone cancer. And like many who get a diagnosis of a serious illness at an advanced age, her first decision wasn’t what the best treatment plan might be but rather whether she should seek treatment at all.
“At the age of 91, I have to make up my mind,” she told People magazine. “I’m not in any pain right now. I’m feeling so terrific and so glad to be above ground.”
Rae, who was treated for pancreatic cancer several years ago, added, “Now I have to figure out whether I want to go have treatment again ...
Source: Healthy Living - The Huffington Post - April 28, 2017 Category: Consumer Health News Source Type: news
Primary Intracranial Extraskeletal Chondrosarcoma Primary Intracranial Extraskeletal Chondrosarcoma
This patient ' s MRI scan revealed a mass which was initially misdiagnosed as a meningioma. What imaging features might have pointed to its true etiology?Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 3, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Schoolboy has jaw built using his LEG BONES after tumour ravaged his face
Adam McCalmont, 16, from Coleraine, Northern Ireland, was diagnosed with mesenchymal chondrosarcoma - a rare form of bone cancer - after complaining of a dull ache in his jaw. (Source: the Mail online | Health)
Source: the Mail online | Health - December 12, 2016 Category: Consumer Health News Source Type: news
Studies point to clinical advantages of proton therapy
New data from clinical trials demonstrate the technology's potential advantages over conventional radiation, including less side effects and survival in some cases, for several harder-to-treat tumors: pancreatic, late-stage, non-small cell lung and chordoma and chondrosarcoma, two rare cancers found in bone or soft tissue. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 19, 2015 Category: Science Source Type: news
ASTRO: Penn Medicine studies point to clinical advantages of proton therapy
(University of Pennsylvania School of Medicine) New data from clinical trials conducted at the Robert Proton Therapy Center demonstrate the technology's potential advantages over conventional radiation, including less side effects and survival in some cases, for several harder-to-treat tumors: pancreatic, late-stage, non-small cell lung and chordoma and chondrosarcoma, two rare cancers found in bone or soft tissue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 19, 2015 Category: Cancer & Oncology Source Type: news
South African woman whose face was DEVOURED by cancer
Tambu Makinzi, 27, from South Africa, was diagnosed with the rare bone cancer chondrosarcoma four years ago. It devoured her nasal and upper jaw bone, leaving her months from death. (Source: the Mail online | Health)
Source: the Mail online | Health - September 11, 2015 Category: Consumer Health News Source Type: news
Survival from rare bone cancer remains low
Ten-year survival of a rare malignancy called mesenchymal chondrosarcoma has been reported to be as low as 20 percent. But a new study has found survival is not as dismal as prior reports. More than half (51 percent) of patients survived at least five years, and 43 percent survived at least 10 years. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 12, 2015 Category: Science Source Type: news
Survival from rare bone cancer remains low
(Loyola University Health System) Among the deadliest cancers is a rare malignancy called mesenchymal chondrosarcoma, which begins in cartilage around bones and typically strikes young adults. Ten-year survival has been reported to be as low as 20 percent. But a Loyola study has found survival is not as dismal as prior reports. Fifty-one percent of patients survived at least five years, and 43 percent survived at least 10 years. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 12, 2015 Category: Cancer & Oncology Source Type: news
Missouri hospital delivers world’s first proton therapy treatment using MEVION S250
Barnes-Jewish Hospital, a member of BJC HealthCare, has delivered the world’s first MEVION S250 proton therapy treatment to a patient with a rare type of cancer called chondrosarcoma at the base of the skull. (Source: Hospital Management)
Source: Hospital Management - December 24, 2013 Category: Hospital Management Source Type: news
